News & events
Q-linea receives US FDA 510(k) clearance for the ASTar® System
Q-linea publish the Annual report for 2023
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), announced today that the Annual Report for the 2023 fiscal year has been...
Read more >
Carnegie Healthcare Seminar 2024 - Mars 6
Strong ASTar results presented at AMCLI
Early study results show ASTar prompted antibiotic therapy modifications in up to 45% of septic patients and enabled appropriate...
Read more >
Year-end report 1 January – 31 December 2023
ASTar installed at two prominent US hospitalsFourth quarter: 1 October–31 December 2023Net sales amounted to SEK 0.1 million (0).The...
Read more >
Q-linea presents at AMCLI
Q-linea creates separate subsidiary for Podler
Load more